Analyze Diet
Veterinary surgery : VS2021; 51(2); 296-302; doi: 10.1111/vsu.13750

Partial parotid sialoadenectomy in a horse with parotid ductal carcinoma: Surgical description and case report.

Abstract: To describe the surgical findings, histopathological features, and long-term outcome for a horse with parotid salivary carcinoma. Methods: Case report ANIMALS: Twelve year old American Quarter Horse gelding. Methods: The gelding was presented for a 10 × 10 cm swelling below the base of the right ear. Ultrasonographic examination revealed a mass involving the right parotid salivary gland. Incisional biopsy was consistent with parotid carcinoma. The tumor was marginally excised. The lateral wall of the guttural pouch was excised with the mass and was reconstructed with a porcine small intestinal submucosal (SIS) sheet. Cisplatin beads were implanted in the wound bed prior to closure. Firocoxib (0.1 mg/kg orally, daily, every 24 h) treatment was initiated. Results: Postoperative complications included right-sided facial nerve paralysis, difficulty with deglutition of fibrous feeds, and surgical site dehiscence. Wound healing was achieved by second intention. Partial improvement in nerve function was observed within the first 6 months. At 12 months postparotidectomy, no sign of tumor reoccurrence or metastatic disease was present, and the gelding returned to work. Conclusions: Partial parotid sialoadenectomy was performed with a favorable long-term outcome. Regional anatomic knowledge is crucial.
Publication Date: 2021-12-01 PubMed ID: 34850982DOI: 10.1111/vsu.13750Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper presents the surgical approach and long-term results of a case where a horse was treated for parotid salivary gland cancer through partial removal of the gland.

Surgical Findings and Procedure

  • The 12 year old American Quarter Horse gelding was observed to have a 10×10 cm swelling below the base of the right ear.
  • A sonogram examination disclosed a formation involving the right parotid salivary gland.
  • An incisional biopsy was executed, which confirmed the diagnosis of parotid carcinoma.
  • The tumor was subsequently marginally removed.
  • The lateral wall of the guttural pouch, a notable structure in horses linked to the middle ear, was also excised along with the mass.
  • The removed part was then reconstructed with a porcine small intestinal submucosal (SIS) sheet, a type of biological tissue often used in surgical treatments for its regenerative properties.
  • To discourage the growth of remaining cancer cells, Cisplatin beads, a form of chemotherapy, were implanted into the wound bed prior to final closure of the surgical site.
  • Post surgery, the horse was placed on a daily oral treatment of Firocoxib, an anti-inflammatory medication typically given to horses.

Postoperative Complications

  • The gelding developed right-sided facial nerve paralysis post surgery. This is a known risk as the facial nerve passes closely to the parotid gland.
  • A condition called dysphasia was noted, which meant the horse had difficulty swallowing fibrous feed.
  • There was also surgical site dehiscence, a situation where a surgical wound reopens before it has adequately healed.
  • However, the wound finally healed by the method called ‘second intention’, a natural process in which a wound heals by granulation tissue formation, contraction, and epithelialization without surgical closure.
  • In the 6 months’ post-operative timeframe, there was a partial improvement in the facial nerve functionality.

Long Term Result

  • By the 12 month mark, there was no sign of recurring or metastatic tumor.
  • The gelding was also able to return to work, demonstrating a successful outcome to the surgery and recovery process.

Conclusion

  • The paper concludes with the assertion that partial parotid sialoadenectomy (removal of part of the parotid gland) showed a promising long-term outcome for the horse.
  • The importance of regional anatomic knowledge, understanding the structure and function of particular body areas, is highlighted as crucial in achieving such results.

Cite This Article

APA
Zetterström SM, Matz BM, Neto RLALT, Lindley SES, Cole RC, Wilhite R, Boone LH. (2021). Partial parotid sialoadenectomy in a horse with parotid ductal carcinoma: Surgical description and case report. Vet Surg, 51(2), 296-302. https://doi.org/10.1111/vsu.13750

Publication

ISSN: 1532-950X
NlmUniqueID: 8113214
Country: United States
Language: English
Volume: 51
Issue: 2
Pages: 296-302

Researcher Affiliations

Zetterström, Sandra M
  • Auburn University, Auburn, Alabama, USA.
Matz, Brad M
  • Auburn University, Auburn, Alabama, USA.
Neto, Rachel L A L T
  • Auburn University, Auburn, Alabama, USA.
Lindley, Stephanie E S
  • Auburn University, Auburn, Alabama, USA.
Cole, Robert C
  • Auburn University, Auburn, Alabama, USA.
Wilhite, Ray
  • Auburn University, Auburn, Alabama, USA.
Boone, Lindsey H
  • Auburn University, Auburn, Alabama, USA.

MeSH Terms

  • Animals
  • Carcinoma, Ductal / veterinary
  • Horse Diseases / surgery
  • Horses
  • Male
  • Parotid Neoplasms / surgery
  • Parotid Neoplasms / veterinary
  • Plastic Surgery Procedures / veterinary
  • Salivary Glands
  • Swine

References

This article includes 29 references
  1. Schumacher J, Schumacher J. Diseases of the salivary glands and ducts of the horse.. Equine Vet Ed 1995;7:313-319.
  2. Kuan EC, Mallen-St Clair J, St John MA. Evaluation of parotid lesions.. Otolaryngol Clin North Am 2016;49:313-325.
  3. Koestner A, Buerger L. Primary neoplasms of the salivary glands in animals compared to similar tumors in man.. Pathol Vet 1965;2:201-226.
  4. Honda K, Tanaka S, Shinohara S. Survival in patients with parotid gland carcinoma-Results of a multi-center study.. Am J Otolaryngol 2018;39:65-70.
  5. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary Parotid Malignancies: A Clinical and Pathologic Review.. Arch Otolaryngol Head Neck Surg 1991;117:307-315.
  6. MacGillivray KC, Sweeney RW, Piero FD. Metastatic melanoma in horses.. J Vet Intern Med 2002;16:452-456.
  7. McConnell EJ, Sanz MG, Kafka UCM, Duncan NM. Parotid salivary gland carcinoma in a geriatric horse.. Equine Vet Ed 2014;26:610-615.
  8. Groom L, Sullins K. Surgical excision of large melanocytic tumours in grey horses: 38 cases (2001-2013).. Equine Vet Ed 2018;30:438-443.
  9. Peddie J, Tobler E, Walker E. Extirpation of the parotid gland in a mare.. Vet Med Small Anim Clin 1971;66:605-606.
  10. Bracegirdle J. Removal of the parotid and mandibular salivary glands from a pony mare.. Vet Rec 1976;98:507.
  11. Chiu AG, Jackman AH, Antunes MB, Feldman MD, Palmer JN. Radiographic and histologic analysis of the bone underlying inverted papillomas.. Laryngoscope 2006;116(9):1617-1620.
  12. Hammer A, Getzy D, Ogilvie G, Klausner J, Kisseberth WC. Salivary gland neoplasia in the dog and cat: survival times and prognostic factors.. J Am Anim Hosp Assoc 2001;37:478-482.
  13. Lim YC, Lee SY, Kim K. Conservative parotidectomy for the treatment of parotid cancers.. Oral Oncol 2005;41:1021-1027.
  14. Shashinder S, Tang I, Velayutham P. A review of parotid tumours and their management: a ten-year-experience.. Med J Malaysia 2009;64:31-33.
  15. Evans S, Thrall D. Postoperative orthovoltage radiation therapy of parotid salivary gland adenocarcinoma in three dogs.. J Am Vet Med Assoc 1983;182:993-994.
  16. Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.. Int J Radiat Oncol Biol Phys 2008;70:660-665.
  17. Airoldi M, Gabriele AM, Gabriele P. Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma.. Tumori 2001;87:14-17.
  18. Lewis AG, Tong T, Maghami E. Diagnosis and management of malignant salivary gland tumors of the parotid gland.. Otolaryngol Clin North Am 2016;49:343-380.
  19. Pellmann R, Jacobi R, Jaugstetter H. Equine juvenile mandibular ossifying fibroma of a male thoroughbred foal treated with cisplatin.. Pferdeheilkunde 2002;18:467-470.
  20. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications.. Vet Comp Oncol 2008;6:1-18.
  21. Rizk S, Robert A, Vandenhooft A, Airoldi M, Kornek G, Machiels J. Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature.. Eur Arch Otorhinolaryngol 2007;264:587-594.
  22. Bergman NS, Urie BK, Pardo AD, Newman RG. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).. J Am Vet Med Assoc 2016;248:1148-1156.
  23. Hovanessian N, Davis JL, McKenzie HC III, Hodgson JL, Hodgson DR, Crisman MV. Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.. J Vet Pharmacol Ther 2014;37(3):243-251.
  24. McEntee MF, Cates JM, Neilsen N. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.. Vet Pathol 2002;39:428-436.
  25. Moore AS, Beam SL, Rassnick KM, Provost P. Long-term control of mucocutaneous squamous cell carcinoma and metastases in a horse using piroxicam.. Equine Vet J 2003;35(7):715-718.
  26. Henney SE, Brown R, Phillips D. Parotidectomy: the timing of post-operative complications.. Eur Arch Otorhinolaryngol 2010;267:131-135.
  27. Mariano F, Da Silva S, Chulan T, De Almeida OP, Kowalski LP. Clinicopathological factors are predictors of distant metastasis from major salivary gland carcinomas.. Int J Oral Maxillofac Surg 2011;40:504-509.
  28. Walvekar RR, Filho PAA, Seethala RR. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.. Head Neck 2011;33:225-231.
  29. Kim Y-H, Chung W-K, Jeong J-U. Evaluation of prognostic factors for the parotid cancer treated with surgery and postoperative radiotherapy.. Clin Exp Otorhinolaryngol 2020;13:69-76.